facebook pixel Skip to main content
Ralph Carson LD RD PhD
  • Presenter: Ralph Carson, LD, RD, PhD
  • Price: $69
  • CME: 1.25 AMA PRA Category 1 Credit™
  • Format: 1 hour video lecture
Enroll Now


There has been increasing interest in the role of oxytocin in the development, maintenance and pathophysiology eating disorders. Oxytocin alters neural pathways that exert prosocial effects and modulates trust, fear, depression, anxiety, trauma, and neuroplasticity. MRIs show that when OXT levels are low in anorexia and will result in hypoactivation of brain regions involved in motivation. Furthermore, research supports the hormone reduces unconscious tendencies to focus on food, body shape and negative emotions. This course explores the potential of exogenous and endogenous oxytocin to improve the outcomes of eating disorder treatment.

Learning Objectives

At the conclusion of this presentation, participants will be able to:

  1. List five ways that oxytocin may be involved with the pathophysiology of anorexia nervosa
  2. Discuss how oxytocin influences neurological pathways and alters activation of key areas of the brain responsible for sustaining anorectic behavior
  3. Illustrate how emotional information from the face, voice and body language are assessed to indicate trustworthiness
  4. Explain how the various variations of the oxytocin gene influence temperament
  5. Identify over a dozen behaviors and techniques identified to naturally increase one’s oxytocin levels.
  6. Argue whether or not oxytocin crosses the blood brain barrier and therapeutically influences one’s behavior and mental state
  7. Describe three ways oxytocin influences appetite and body weight
  8. Report on how touch influences oxytocin and cortisol levels in the blood.
  9. Propose how intranasal oxytocin products may be harmful and counterproductive in the treatment of anorexia nervosa

Accreditation Information

Please click to expand each section and view accreditation information.

• CME Information

June 20, 2022 through June 19, 2024

ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Comprehensive Psychiatric Resources, Inc. MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.

DESIGNATION STATEMENT: MedicusCME designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Oxytocin is a hormone involved in social bonding. Some of the latest research suggests that oxytocin may have a role in mental health treatment, either by exogenous administration or techniques that increase endogenous levels.


  • Explain the physiology, emotional and social effects of oxytocin

  • Identify and describe the therapeutic potential of oxytocin in eating disorders and other mental health conditions

In order to receive AMA PRA Category 1 credit™, participants must do the following:

  • Read the learning objectives and faculty disclosures

  • Participate in the activity, review course content and learning strategies, resources and support materials provided

  • Complete the post-test and activity evaluation

  • Achieve a score of 80% or higher on the post-test

James Greenblatt, MD
Chief Medical Officer and Vice President of Medical Services
Walden Behavioral Care, Waltham, Massachusetts

Assistant Clinical Professor of Psychiatry
Tufts University School of Medicine
Boston, Massachusetts

Ralph Carson, CED-RD, RD, PhD
Senior Clinical and Research Advisor
Eating Recovery Center-Pathlight Mood and Anxiety
Clinical Nutritional Advisor
Pine Grove Behavioral Health and Addiction Services
Hattiesburg, Mississippi

MedicusCME requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to MedicusCME policy.

James Greenblatt, MD has disclosed a financial relationship with Pure Encapsulations and Jaymac Pharmaceuticals for his role as consultant.

All other planners and faculty, including MedicusCME planners and managers, have no relevant financial relationships with ineligible companies to disclose. Any relevant financial relationships listed for planners or content contributors have been mitigated according to MedicusCME policies.

This activity is not supported by funds from an ACCME-defined ineligible company.

In accordance with the Health Insurance Portability and Accountability Act (HIPAA), this educational activity, especially when utilizing patient cases for learning demonstration, will not include individually identifiable health information.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Let’s redefine mental wellness together.

Sign-up now for the latest in functional news and research, course launches, exclusive offers and more.

Please enable JavaScript in your browser to complete this form.

By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.